Ultragenyx Pharmaceutical Inc. - Common Stock (RARE)
CUSIP: 90400D108
Q3 2017 13F Holders as of 30 Sep 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 98,367,418
- Total 13F shares
- 40,596,743
- Share change
- -682,523
- Total reported value
- $2,164,481,778
- Put/Call ratio
- 160%
- Price per share
- $53.26
- Number of holders
- 148
- Value change
- -$37,427,143
- Number of buys
- 71
- Number of sells
- 64
Quarterly Holders Quick Answers
What is CUSIP 90400D108?
CUSIP 90400D108 identifies RARE - Ultragenyx Pharmaceutical Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 90400D108:
Top shareholders of RARE - Ultragenyx Pharmaceutical Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.3%
|
5,247,141
|
$325,899,000 | — | 30 Jun 2017 | |
| Capital Research Global Investors |
13F
|
Company |
5.3%
|
5,183,330
|
$321,937,000 | — | 30 Jun 2017 | |
| FMR LLC |
13F
|
Company |
3.9%
|
3,804,225
|
$236,280,000 | — | 30 Jun 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.6%
|
3,497,591
|
$217,237,000 | — | 30 Jun 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.2%
|
3,130,273
|
$194,421,000 | — | 30 Jun 2017 | |
| Capital International Investors |
13F
|
Company |
2.4%
|
2,374,985
|
$147,510,000 | — | 30 Jun 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.8%
|
1,761,589
|
$109,412,000 | — | 30 Jun 2017 | |
| STATE STREET CORP |
13F
|
Company |
1.6%
|
1,536,285
|
$95,417,000 | — | 30 Jun 2017 | |
| COLUMBIA WANGER ASSET MANAGEMENT LLC |
13F
|
Company |
1.4%
|
1,364,434
|
$84,745,000 | — | 30 Jun 2017 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.7%
|
689,206
|
$42,807,000 | — | 30 Jun 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.55%
|
539,761
|
$33,524,000 | — | 30 Jun 2017 | |
| NORGES BANK |
13F
|
Company |
0.54%
|
528,530
|
$32,827,000 | — | 30 Jun 2017 | |
| CAPITAL GUARDIAN TRUST CO |
13F
|
Company |
0.52%
|
512,430
|
$31,827,000 | — | 30 Jun 2017 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.52%
|
511,740
|
$31,784,000 | — | 30 Jun 2017 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.6%
|
589,211
|
$31,729,000 | — | 30 Jun 2017 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.49%
|
480,779
|
$29,861,000 | — | 30 Jun 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.49%
|
477,401
|
$29,651,000 | — | 30 Jun 2017 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.48%
|
470,032
|
$29,194,000 | — | 30 Jun 2017 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.48%
|
467,500
|
$29,036,000 | — | 30 Jun 2017 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.42%
|
417,100
|
$25,906,000 | — | 30 Jun 2017 | |
| ROCKEFELLER FINANCIAL SERVICES INC |
13F
|
Company |
0.42%
|
408,379
|
$25,365,000 | — | 30 Jun 2017 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.37%
|
360,107
|
$22,367,000 | — | 30 Jun 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
348,239
|
$21,629,000 | — | 30 Jun 2017 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
337,115
|
$20,938,000 | — | 30 Jun 2017 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.33%
|
322,497
|
$20,030,000 | — | 30 Jun 2017 | |
| Invesco Ltd. |
13F
|
Company |
0.27%
|
261,584
|
$16,247,000 | — | 30 Jun 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.27%
|
260,708
|
$16,193,000 | — | 30 Jun 2017 | |
| CAPITAL INTERNATIONAL LTD /CA/ |
13F
|
Company |
0.26%
|
259,700
|
$16,130,000 | — | 30 Jun 2017 | |
| AXA S.A. |
13F
|
Company |
0.24%
|
236,653
|
$14,699,000 | — | 30 Jun 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.23%
|
224,261
|
$13,929,000 | — | 30 Jun 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.22%
|
219,415
|
$13,628,000 | — | 30 Jun 2017 | |
| Capital World Investors |
13F
|
Company |
0.21%
|
210,000
|
$13,043,000 | — | 30 Jun 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.21%
|
207,327
|
$12,875,000 | — | 30 Jun 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.2%
|
194,740
|
$12,095,000 | — | 30 Jun 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
175,836
|
$10,921,000 | — | 30 Jun 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.17%
|
169,886
|
$10,552,000 | — | 30 Jun 2017 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.17%
|
167,785
|
$10,422,000 | — | 30 Jun 2017 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.16%
|
160,500
|
$9,969,000 | — | 30 Jun 2017 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.13%
|
127,308
|
$7,907,000 | — | 30 Jun 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.13%
|
126,409
|
$7,852,000 | — | 30 Jun 2017 | |
| Capital International Sarl |
13F
|
Company |
0.13%
|
124,320
|
$7,722,000 | — | 30 Jun 2017 | |
| Capital Bank & Trust Co |
13F
|
Company |
0.12%
|
121,961
|
$7,575,000 | — | 30 Jun 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.12%
|
118,703
|
$7,373,000 | — | 30 Jun 2017 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.11%
|
112,296
|
$6,975,000 | — | 30 Jun 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.1%
|
101,774
|
$6,320,000 | — | 30 Jun 2017 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
87,400
|
$5,428,000 | — | 30 Jun 2017 | |
| GAM Holding AG |
13F
|
Company |
0.08%
|
78,100
|
$4,851,000 | — | 30 Jun 2017 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.08%
|
76,927
|
$4,778,000 | — | 30 Jun 2017 | |
| Iguana Healthcare Management, LLC |
13F
|
Company |
0.08%
|
75,000
|
$4,658,000 | — | 30 Jun 2017 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.07%
|
73,412
|
$4,559,000 | — | 30 Jun 2017 |
Institutional Holders of Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) as of Q3 2017
As of 30 Sep 2017,
Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) was held by
148 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,596,743 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, BlackRock Inc., FMR LLC, VANGUARD GROUP INC, Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, COLUMBIA WANGER ASSET MANAGEMENT LLC, STATE STREET CORP, and PICTET ASSET MANAGEMENT LTD.
This page lists
148
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2017 vs Q2 2017 Across Filers
Q2 2017 holders
154
Q3 2017 holders
148
Holder diff
-6
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 Value $ | Q3 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.